Ascension Health Ventures, the $200m venture investment division of US medical company Ascension Health, has become the second corporate venturing unit to back Phreesia, a US-based provider of software for the doctor’s waiting room. Ascension led the $16m series D round for Phreesia, along with the company’s previous investors. BlueCross BlueShield Venture Partners, a $116m…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
